OakChart

Kiniksa Pharmaceuticals International Plc

KNSAHealthcare·Drug Manufacturers - Specialty & Generic·United Kingdom·Mid·NASD·Nov 11 • 3:59 PM ET

95.76+0.74 (0.78%)
2026-11-12 00:07 CET
Market cap
7,465.88 USD m
Revenue, TTM
945.96 USD m
Net income, TTM
109.57 USD m
Free cash flow, TTM
197.20 USD m
EPS diluted, TTM
1.31
P/E
73.06
Compare

Price

KNSA against its 20, 50 and 200-day averages
2050200beat
40.0060.0080.00100.003.4M6.8MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26KNSAclose 95.7620-day 87.8850-day 81.53200-day 62.3095.7652w high

3.6% under the 52-week high of 99.31 on 9 Nov 2026. 52-week low 37.02 on 15 Jan 2026. Last 15 sessions, 40.5% high to low

Volume 0.88× normal · the line is the 50-bar volume average

Profile

KNSA
52-week range, 94% of the way up
37.0299.31

Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company was founded on April 9, 2024 and is headquartered in London, United Kingdom.

IndexRUT
Employees366
IPOMay 24, 2018
Beta0.08
ATR, 14d4.89
Rel volume0.88
Short float9.43%
Insider own42.05%
Inst own59.86%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap7.52B
Enterprise Value6.96B
Income109.57M
Sales945.96M
Book/sh9.05
Cash/sh7.24
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees366
IPOMay 24, 2018

Ratios

P/E73.06
Forward P/E47.28
PEG0.84
P/S7.95
P/B10.58
P/C13.23
P/FCF38.15
EV/EBITDA52.61
EV/Sales7.36
Quick Ratio3.35
Current Ratio3.91
Debt/Eq0.01
LT Debt/Eq0.01
Option/ShortYes / Yes

Earnings

EPS (ttm)1.31
EPS next Y2.03
EPS next Q0.25
EPS this Y97.88%
EPS next Y36.47%
EPS next 5Y55.96%
EPS past 3/5Y-34.04% -
Sales past 3/5Y45.45% -
EPS Y/Y TTM192.34%
Sales Y/Y TTM58.19%
EPS Q/Q142.08%
Sales Q/Q58.12%
EarningsOct 27 BMO
EPS/Sales Surpr.50.94% 9.71%

Ownership

Insider Own42.05%
Insider Trans-2.46%
Inst Own59.86%
Inst Trans2.44%
ROA12.92%
ROE17.59%
ROIC15.34%
Gross Margin54.21%
Oper. Margin13.79%
Profit Margin11.58%
SMA208.97%
SMA5017.45%
SMA20053.70%
Trades-

Technical

Shs Outstand48.75M
Shs Float45.53M
Short Float9.43%
Short Ratio6.48
Short Interest4.29M
52W High99.31 -3.57%
52W Low37.02 158.67%
Volatility6.43% 5.58%
ATR (14)4.89
RSI (14)59.59
Beta0.08
Rel Volume0.88
Avg Volume662.87K
Volume580,990

Performance

Perf Week-0.37%
Perf Month21.94%
Perf Quarter23.04%
Perf Half Y61.98%
Perf YTD132.15%
Perf Year136.04%
Perf 3Y563.16%
Perf 5Y623.26%
Perf 10Y-
Recom1.00
Target Price109.43
Prev Close95.02
Price95.76
Change %0.78%

Analyst ratings

latest 10 of 11
DateActionAnalystRating changeTargetImplied
Sep 30, 2026InitiatedWWells FargoOverweight$87-9.1%
Feb 19, 2026InitiatedCCanaccord GenuityBuy$62-35.3%
Sep 29, 2025InitiatedTTD CowenBuy$60-37.3%
Mar 13, 2025InitiatedCCitigroupBuy$40-58.2%
Sep 13, 2024InitiatedJJefferiesBuy$40-58.2%
May 03, 2024InitiatedWWells FargoOverweight$34-64.5%
Jun 29, 2020ReiteratedBBofA SecuritiesBuy$25 → $40-58.2%
Apr 01, 2020InitiatedBBofA/MerrillBuy$25-73.9%
Mar 11, 2019InitiatedBBarclaysOverweight$26-72.8%
Dec 12, 2018ReiteratedWWedbushOutperform$31 → $33-65.5%

Peers

Mkt cap
TickerCompanyMkt cap
CRDLCardiol Therapeutics Inc121.87M
BCRXBiocryst Pharmaceuticals Inc1.97B
ALKSAlkermes plc8.05B
CYTKCytokinetics Inc8.15B
MIRMMirum Pharmaceuticals Inc6.18B
KRYSKrystal Biotech Inc9.15B
ARGXArgen X SE ADR61.48B
REGNRegeneron Pharmaceuticals Inc99.23B
PTCTPTC Therapeutics Inc5.42B
ACADAcadia Pharmaceuticals Inc3.17B

Insider trading

latest 14 of 90
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Patel Sanj KCHAIRMAN & CEONov 04 '26Option Exercise17.92145,7632,612,073925,800Nov 06 04:52 PM
Patel Sanj KCHAIRMAN & CEONov 04 '26Sale94.71151,30014,330,278774,500Nov 06 04:52 PM
Patel Sanj KCHAIRMAN & CEONov 03 '26Option Exercise11.71130,3261,525,6231,000,207Nov 03 07:30 PM
Patel Sanj KCHAIRMAN & CEONov 02 '26Option Exercise8.8353,381471,354959,314Nov 03 07:30 PM
Patel Sanj KCHAIRMAN & CEOOct 30 '26Option Exercise8.8347,530419,690999,324Nov 03 07:30 PM
Patel Sanj KCHAIRMAN & CEONov 03 '26Sale93.27220,17020,535,459780,037Nov 03 07:30 PM
Patel Sanj KCHAIRMAN & CEOOct 30 '26Sale93.1292,8918,649,772905,933Nov 03 07:30 PM
Patel Sanj KCHAIRMAN & CEONov 02 '26Sale91.8689,4338,215,096869,881Nov 03 07:30 PM
Ragosa MarkCHIEF FINANCIAL OFFICERNov 02 '26Option Exercise13.0436,783479,73857,637Nov 03 06:32 PM
Ragosa MarkCHIEF FINANCIAL OFFICERNov 02 '26Sale92.1636,7833,389,97520,854Nov 03 06:32 PM
Paolini John F.CHIEF MEDICAL OFFICEROct 30 '26Option Exercise24.3877,5871,891,829147,509Nov 03 06:28 PM
Paolini John F.CHIEF MEDICAL OFFICERNov 02 '26Option Exercise22.4818,413413,94188,335Nov 03 06:28 PM
Paolini John F.CHIEF MEDICAL OFFICEROct 30 '26Sale93.0277,5877,217,39769,922Nov 03 06:28 PM
Paolini John F.CHIEF MEDICAL OFFICERNov 02 '26Sale93.3918,4131,719,67069,922Nov 03 06:28 PM

Held by

AUM
TickerCompanyAUM
IWMiShares Russell 2000 Index FundAUM: 77.38B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
VBKVanguard Morningstar Small-Cap Growth ETFAUM: 22.34B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.51B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
DFACU.S. Core Equity 2 Portfolio-ETF Class SharesAUM: 49.14B
PSCPrincipal U.S. Small-Cap ETFAUM: 2.68B
VHTVanguard Health Care ETFAUM: 21.51B

News

latest 14 of 100

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-270.5600.3710.572285.97260.668
2026Q22026-07-280.3000.3000.305243.6226.498
2026Q12026-04-280.2700.2020.274214.27206.118
2025Q42026-02-240.1700.3450.174202.13200.818
2025Q32025-10-280.2300.3240.230180.86167.397
2025Q22025-07-290.2300.2200.229156.8146.486
2025Q12025-04-290.1100.1290.112137.79131.887
2024Q42025-02-25-0.1200.024-0.123122.54123.425
2024Q32024-10-29-0.1800.023-0.177112.21111.516
2024Q22024-07-23-0.060-0.077-0.055108.6390.604
2024Q12024-04-23-0.250-0.082-0.25179.9076.972
2023Q42024-02-280.350-0.0980.34783.4073.254
2023Q32023-10-31-0.200-0.166-0.19767.0564.554
2023Q22023-07-250.210-0.1420.20971.4752.064
2023Q12023-05-02-0.180-0.159-0.17648.3546.614
2022Q42023-02-280.060-0.2030.06361.8845.124

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-2.990-3.048-2.9950.000.00
2020FY-2.610-2.434-2.6100.000.00
2021FY-2.300-2.185-2.30338.5437.40
2022FY2.6002.3802.604220.18203.34
2023FY0.200-0.1720.196270.26260.12
2024FY-0.600-0.394-0.605423.24424.18
2025FY0.7500.9740.757677.56676.45
2026FY-1.484--1,050
2027FY-2.025--1,325
2028FY-2.845--1,548
2029FY-3.027--1,677
2030FY-7.007--1,941

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-10-29770306.56302.9314.6
2026Q4S2026-10-28880306.78302.9314.6
2026Q4S2026-10-27870303.17275.18314.6
2026Q4S2026-10-22810277.6273.63284.9
2026Q4S2026-10-21800276.25273.63279.9
2026Q4S2026-10-15801276.25273.63279.9
2026Q4S2026-10-11801276.16273.63279.9
2026Q4S2026-08-12871276.16273.63279.9
2026Q4S2026-08-11871276.16273.63279.9
2026Q4S2026-08-07871276.16273.63279.9
2026Q4S2026-07-31880279.1273.63300.19
2026Q4S2026-07-28880279.08273.63300.19
2026Q4S2026-07-12810258.03251.19274.38
2026Q4S2026-07-09850258.03251.19274.38

Estimate history

EPS, annual-1.312-2.086-2.995-2.61-2.3032.6040.196-0.6050.7471.3107
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.177-0.1230.1120.2290.230.1740.2740.3050.558
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual000038.544220.18270.259423.239677.564945.96
Period201720182019202020212022202320242025TTM
Sales, quarterly112.214122.536137.785156.797180.855202.127214.266243.6285.97
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual49.44749.4949.4968.21569.0669.69870.46172.51676.29478.484
Period201720182019202020212022202320242025MRQ
Shares, quarterly72.15872.51672.79774.03275.42576.29476.68977.9878.484
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue945.96677.56423.24270.26220.1838.540.000.000.00
Cost of Goods Sold Incl. D&A433.19307.41189.6791.0451.1914.023.813.280.29
Gross Profit512.78370.15233.57179.22168.9924.52-3.81-3.28-0.29
Selling, General and Administrative Excl. Other382.31292.93279.19204.41159.22181.16153.56166.68107.87
Research and Development135.1696.66111.1774.9964.3197.84109.64132.9386.60
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income130.4777.22-45.62-25.209.77-156.64-157.36-169.96-108.16
Interest Expense0.000.000.000.000.000.000.000.000.00
Unusual Expense0.000.000.000.000.000.000.00--
Net Income Before Taxes146.1588.87-36.15-16.6511.03-156.54-156.23-163.91-103.44
Income Taxes36.5829.867.04-30.74-172.341.395.15-2.05-0.21
Consolidated Net Income109.5759.01-43.1914.08183.36-157.92-161.38-161.87-103.23
Net Income From Continuing Operations109.5759.01-43.1914.08183.36-157.92-161.38-161.87-103.23
Net Income109.5759.01-43.1914.08183.36-157.92-161.38-161.87-103.23
EPS (Recurring)1.290.75-0.600.202.60-2.30-2.61-2.99-2.09
EPS (Basic, Before Extraordinaries)1.420.80-0.600.202.64-2.30-2.61-2.99-2.09
EPS (Diluted)1.310.75-0.600.202.60-2.30-2.61-2.99-2.09
EBITDA132.3678.78-43.92-23.0913.99-152.55-153.56-166.68-107.87
Non-Operating Income (Expense)15.6911.659.468.541.250.101.136.054.72
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense35.5429.2324.2521.4519.8418.3815.2411.014.50
Price To Earnings Ratio72.5072.50--7.50----
Price To Sales Ratio6.704.813.344.674.7920.94---
Gross Margin54.2154.6355.1966.3176.7563.62---
Operating Margin13.7911.40-10.78-9.324.44-406.38---
Net Margin11.588.71-10.215.2183.28-409.72---
Shares Outstanding78.4876.2972.5270.4669.7069.0668.2249.4949.49
Market Capitalization7,465.887,465.881,428.151,233.731,041.59810.821,202.89606.991,389.51

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue285.97243.60214.27202.13180.85156.80137.78122.54
Cost of Goods Sold Incl. D&A133.77111.8196.5291.1083.5971.0361.6966.17
Gross Profit152.20131.79117.75111.0397.2685.7676.0956.36
Selling, General and Administrative Excl. Other97.97104.6088.4891.2673.2465.6062.8275.66
Research and Development32.6040.7327.3334.4924.1418.7419.2935.13
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income54.2427.1929.2719.7724.0220.1613.27-19.30
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes59.0631.1432.6823.2727.1622.8815.56-16.98
Income Taxes11.715.7110.099.078.725.047.03-8.09
Consolidated Net Income47.3425.4322.5914.2018.4317.838.54-8.89
Net Income From Continuing Operations47.3425.4322.5914.2018.4317.838.54-8.89
Net Income47.3425.4322.5914.2018.4317.838.54-8.89
EPS (Recurring)0.560.300.270.170.230.230.11-0.12
EPS (Basic, Before Extraordinaries)0.610.330.300.190.250.240.12-0.12
EPS (Diluted)0.560.300.270.170.230.230.11-0.12
EBITDA54.7327.6729.7320.2324.4120.5213.62-18.90
Non-Operating Income (Expense)4.823.953.413.503.142.722.292.32
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense10.329.197.948.098.017.016.126.56
Price To Earnings Ratio72.5070.4864.6091.99944.77---
Price To Sales Ratio6.706.345.264.975.204.073.513.38
Gross Margin53.2254.1054.9554.9353.7854.7055.2346.00
Operating Margin18.9711.1613.669.7813.2812.869.63-15.75
Net Margin16.5610.4410.547.0210.1911.376.20-7.25
Shares Outstanding78.4877.9876.6976.2975.4274.0372.8072.52
Market Capitalization7,465.884,920.193,685.173,126.572,877.602,019.101,613.431,428.15

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments414.07243.63206.37190.61182.20323.69233.38307.3045.66
Short Term Receivables15.5941.7221.2720.323.980.000.000.000.00
Inventories54.9026.3631.1221.603.670.000.000.000.00
Other Current Assets42.6120.0817.5410.546.589.568.256.451.44
Total Current Assets527.18331.80276.30243.06196.45333.25241.63313.7547.10
Net Property, Plant & Equipment11.7511.0412.667.048.3810.628.326.360.12
Total Investments and Advances0.000.000.000.000.000.000.210.210.00
Intangible Assets15.2516.2517.2518.2519.250.000.000.000.00
Deferred Tax Assets198.15211.15219.28185.500.000.014.371.220.24
Other Assets11.3110.310.835.828.725.590.000.430.03
Total Assets763.63580.55526.32459.67232.80349.46254.53321.9647.49
Short Term Debt Incl. Current Port. of LT Debt2.991.992.253.303.382.111.700.000.00
Accounts Payable2.032.048.257.901.870.505.6910.921.22
Other Current Liabilities134.1796.5953.1735.8739.5829.2420.4431.6416.21
Total Current Liabilities139.18100.6263.6747.0744.8231.8527.8342.5517.43
Long Term Debt6.517.8610.012.622.674.880.950.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities50.3333.6313.8113.840.270.810.330.140.00
Total Liabilities196.03142.1287.4863.5247.7637.5329.1142.7017.43
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00119.77
Common Equity567.61438.44438.84396.15185.04311.94225.42279.27-89.71
Total Shareholders Equity567.61438.44438.84396.15185.04311.94225.42279.2730.06
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity567.61438.44438.84396.15185.04311.94225.42279.2730.06
Total Liabilities & Stockholders Equity763.63580.55526.32459.67232.80349.46254.53321.9647.49
Book Value Per Share7.446.056.235.682.684.574.555.64-1.81
Tangible Book Value Per Share7.245.825.985.422.404.574.555.64-1.81
Full-Time Employees366315297220215168137111-
Price to Book Ratio10.503.273.042.714.393.862.434.983.86
Return on Assets8.78-7.802.8652.96-54.24-53.44-56.16-55.88-124.80
Return on Equity11.73-9.853.3763.10-63.55-60.06-64.15-66.74-154.04
Return on Invested Capital10.28-9.683.1445.98-84.13-50.94-71.50-36.96-215.80
Quick Ratio3.393.043.854.714.3010.468.687.372.70
Current Ratio3.793.304.345.164.3810.468.687.372.70

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income109.5759.01-43.1914.08183.36-157.92-161.38-161.87-103.23
Depreciation1.901.551.702.345.444.993.813.280.29
Other Funds (Non Cash)49.0139.6334.2529.3125.0725.9421.0020.404.58
Funds from Operations164.23113.190.8811.9528.38-126.99-132.22-141.34-99.34
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital34.6024.7924.811.35-22.570.69-4.32-17.0218.33
Cash from Operating Activities198.84137.9925.6913.305.81-126.30-136.53-158.37-81.01
Capital Expenditures-1.64-1.57-0.28-0.13-0.10-20.41-0.28-3.20-5.29
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00-
Sale of Fixed Assets and Businesses0.000.000.030.000.090.000.000.00-
Purchase or Sale of Investments-313.24-187.4337.92-29.43-8.06149.05-23.1652.42-233.91
Purchase of Investments-568.12-386.92-202.01-204.93-135.86-157.25-430.21-488.77-402.01
Sale Or Maturity of Investments254.88199.49239.94175.51127.80306.30407.05541.19168.10
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-314.87-188.9937.67-29.56-8.08128.63-23.4449.21-239.20
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock22.8433.0212.271.503.425.88227.0984.11346.74
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock22.8433.0212.271.503.425.88227.0984.11346.74
Proceedsfrom Stock Options-15.78-7.73-4.98-2.210.000.00220.5382.99346.36
Issuance or Reduction of Debt, Net0.000.000.000.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.00-0.900.000.000.000.00
Other Financing Activities Uses0.000.000.000.00-0.900.000.000.000.00
Cash from Financing Activities22.8433.0212.271.502.525.88227.0984.11346.74
Net Change in Cash-93.20-17.9875.63-14.760.248.2267.11-25.0526.53
Free Cash Flow197.20136.4225.4113.175.70-126.71-136.81-161.57-86.30
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow32.1323.8855.5995.78185.01----
Deferred Taxes & Investment Tax Credit-13.008.13-33.79-185.500.014.36-3.16-0.98

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments568.76525.93468.09414.07352.10307.78
Short Term Receivables30.7823.4923.2215.5951.7431.91
Inventories108.0370.9373.1454.9041.4048.18
Other Current Assets42.5348.2829.7142.6130.2932.44
Total Current Assets750.10668.63594.17527.18475.53420.31
Net Property, Plant & Equipment9.8510.9311.3211.7511.7311.38
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets14.5014.7515.0015.2515.5015.75
Deferred Tax Assets198.04190.97193.63198.15201.29205.51
Other Assets10.7510.8311.1611.318.298.20
Total Assets983.24896.11825.28763.63712.33661.15
Short Term Debt Incl. Current Port. of LT Debt3.974.013.172.992.702.52
Accounts Payable4.1112.4024.402.036.158.96
Other Current Liabilities183.78154.83129.04134.17114.75106.35
Total Current Liabilities191.85171.25156.61139.18123.59117.83
Long Term Debt3.924.885.866.517.027.24
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities77.2865.8357.1350.3346.3441.07
Total Liabilities273.05241.96219.59196.03176.95166.14
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity710.19654.15605.69567.61535.38495.01
Total Shareholders Equity710.19654.15605.69567.61535.38495.01
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity710.19654.15605.69567.61535.38495.01
Total Liabilities & Stockholders Equity983.24896.11825.28763.63712.33661.15
Book Value Per Share9.058.397.907.447.106.69
Tangible Book Value Per Share8.868.207.707.246.896.47
Full-Time Employees---366--
Price to Book Ratio10.508.106.475.815.814.40
Return on Assets12.9210.3610.268.785.670.80
Return on Equity17.5914.0413.7411.737.391.03
Return on Invested Capital6.633.863.692.473.403.55
Quick Ratio3.353.493.333.393.513.16
Current Ratio3.913.903.793.793.853.57

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income47.3425.4322.5914.2018.4317.83
Depreciation0.490.470.470.470.380.36
Other Funds (Non Cash)13.7412.7612.3010.2111.658.92
Funds from Operations55.0141.3339.8828.0234.6929.76
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-7.465.8710.3225.88-1.02-1.67
Cash from Operating Activities47.5547.2050.2053.8933.6828.09
Capital Expenditures-0.18-0.66-0.16-0.63-0.67-0.17
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments-138.38-72.92-31.75-70.18-62.08-3.72
Purchase of Investments-170.12-109.62-177.41-110.96-146.16-34.32
Sale Or Maturity of Investments31.7436.70145.6640.7884.0830.61
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-138.56-73.58-31.92-70.81-62.76-3.88
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-3.0012.116.077.6611.9010.70
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock-3.0012.116.077.6611.9010.70
Proceedsfrom Stock Options-9.07-5.47-0.32-0.92-4.35-2.05
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities-3.0012.116.077.6611.9010.70
Net Change in Cash-94.02-14.2824.36-9.26-17.1834.91
Free Cash Flow47.3746.5350.0453.2633.0127.93
Price to Free Cash Flow32.1329.1724.1624.6630.5532.44

Revenue breakdown

Collaboration2024: 6.21M
Product2024: 417.03M 2025: 677.56M
Outside United States and United Kingdom2024: 875.00K
United Kingdom2024: 930.00K 2025: 814.00K
United States2024: 421.43M 2025: 676.75M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-309.43%4.3M45.5M631.30K
2026-10-158.36%3.8M45.0M587.16K
2026-09-308.39%3.8M45.0M603.01K
2026-09-158.61%3.9M45.0M739.76K
2026-08-318.42%3.8M45.0M732.86K
2026-08-149.51%4.3M45.1M754.17K
2026-07-319.55%4.3M45.2M775.67K
2026-07-1510.41%4.5M43.3M816.72K
2026-06-309.59%4.2M43.3M798.67K
2026-06-156.82%2.9M43.2M664.40K
2026-05-297.02%3.0M43.3M702.40K
2026-05-157.18%3.2M44.3M725.71K
2026-04-307.98%3.5M44.3M698.36K
2026-04-159.33%4.1M43.9M628.81K
2026-03-319.32%4.1M43.9M655.52K
2026-03-138.59%3.8M43.9M615.61K
2026-02-277.71%3.4M43.9M546.07K
2026-02-137.08%3.1M43.2M495.41K
2026-01-307.07%3.1M43.3M491.80K
2026-01-157.75%3.4M43.3M484.61K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call20.0073.5078.4059.558.2452.000.000.998-0.0270.001
call22.5071.0076.000.007.6210.000.000.991-0.0930.003
call25.0068.5073.5056.357.1591.000.000.978-0.2400.008
call30.0063.5068.5018.106.2370.000.000.974-0.2390.009
call35.0058.5063.4029.925.42025.000.000.971-0.2370.010
call40.0053.5058.4036.004.7852.000.000.966-0.2340.011
call45.0048.5053.4031.404.23220.000.000.961-0.2310.012
call50.0043.5048.4027.203.7413650.000.956-0.2260.014
call55.0038.5043.4025.403.2982.000.000.950-0.2210.015
call60.0033.5038.4029.552.8922.000.000.942-0.2140.017
call65.0028.5033.4030.302.5152710.000.933-0.2070.019
call70.0023.5028.3024.402.13111.000.000.922-0.1980.022
call75.0018.5023.3020.301.7988.000.000.907-0.1870.025
call80.0014.2018.5013.101.5271242.000.887-0.1740.029
call85.009.7013.109.501.11514210.000.856-0.1560.034
call90.006.408.707.300.91552813.000.687-0.3000.053
call95.003.604.504.000.6865902530.553-0.2880.059
call1002.052.302.200.6562,1998090.383-0.2490.057
call1050.851.351.100.7281,36079.000.230-0.1910.045
call1100.550.800.700.7501,8741,1260.131-0.1360.032
call1150.003.202.550.9122.001.000.113-0.1480.028
call1200.001.850.501.0594.000.000.100-0.1580.026
call1250.004.900.621.19618.000.000.091-0.1660.024
call1300.004.900.001.3230.000.000.084-0.1730.023
put20.000.000.050.033.93761.002.00-0.002-0.0240.001
put22.500.000.250.004.3490.000.00-0.009-0.0810.004
put25.000.004.900.004.7610.000.00-0.015-0.1510.006
put30.000.004.900.004.1430.000.00-0.018-0.1510.006
put35.000.004.900.003.6260.000.00-0.021-0.1490.007
put40.000.004.900.003.1820.000.00-0.024-0.1470.008
put45.000.004.902.302.79111.000.00-0.027-0.1440.009
put50.000.004.905.922.4422.000.00-0.031-0.1410.010
put55.000.004.900.002.4630.000.00-0.050-0.2150.015
put60.000.005.0018.602.1391.000.00-0.058-0.2080.017
put65.000.005.000.501.83937.000.00-0.067-0.2000.019
put70.000.004.500.201.55629.000.00-0.078-0.1900.022
put75.000.004.900.451.28715.000.00-0.093-0.1790.025
put80.000.000.900.321.02757.000.00-0.113-0.1650.029
put85.000.050.900.750.7721013.00-0.144-0.1460.034
put90.000.003.301.841.00121.001.00-0.313-0.2900.053
put95.001.055.403.260.9842120.00-0.447-0.2780.059
put1004.308.507.861.02412.000.00-0.617-0.2370.057
put1058.1012.500.001.1270.000.00-0.770-0.1790.045
put11012.6017.000.001.2630.000.00-0.869-0.1240.032
put11517.7022.000.001.4660.000.00-0.887-0.1350.028
put12022.3026.500.001.5360.000.00-0.900-0.1450.026
put12527.4031.500.001.7010.000.00-0.909-0.1520.024
put13032.1036.500.001.8540.000.00-0.916-0.1590.023

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-10-30SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-10-30SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-10-30SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-10-30SEC
2026-11-02144Filing for proposed sale of securities under Rule 144.SEC
2026-10-30144Filing for proposed sale of securities under Rule 144.SEC
2026-10-30144Filing for proposed sale of securities under Rule 144.SEC
2026-10-30144Filing for proposed sale of securities under Rule 144.SEC
2026-10-30144Filing for proposed sale of securities under Rule 144.SEC
2026-10-278-KCurrent report2026-10-27SEC
2026-10-2710-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-228-KCurrent report2026-10-17SEC
2026-09-03144Filing for proposed sale of securities under Rule 144.SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-07-15SEC
2026-08-214Statement of changes in beneficial ownership of securities2026-08-19SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-08-01SEC
2026-07-314Statement of changes in beneficial ownership of securities2026-07-29SEC
2026-07-29SCHEDULE 13GSEC
2026-07-29144Filing for proposed sale of securities under Rule 144.SEC
2026-07-29144Filing for proposed sale of securities under Rule 144.SEC
2026-07-288-KCurrent report2026-07-28SEC
2026-07-2810-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-064Statement of changes in beneficial ownership of securities2026-07-01SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110050.77M6
2026-100026.33M4
2026-0900369.38K1
2026-080000
2026-0700299.09K1
2026-060000
2026-05005.76M2
2026-040028.28M9
2026-03001.79M1
2026-02001.62M6
2026-0100502.68K1
2025-12003.11M3
2025-11001.34M3

Institutional holders

Manager% owned
FMR LLC9.60%
Rubric Capital Management LP5.20%
BAKER BROS. ADVISORS LP3.68%
BlackRock, Inc.3.56%
TANG CAPITAL MANAGEMENT LLC2.94%
VANGUARD PORTFOLIO MANAGEMENT LLC2.48%
VANGUARD CAPITAL MANAGEMENT LLC1.77%
MORGAN STANLEY1.31%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP1.24%
Spruce Street Capital LP1.19%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND1.71%
iShares Russell 2000 ETF1.42%
Select Health Care Portfolio1.24%
VANGUARD SMALL-CAP INDEX FUND1.24%
Strategic Advisers Fidelity U.S. Total Stock Fund0.87%
Select Biotechnology Portfolio0.82%
Fidelity Small Cap Growth Fund0.74%
VANGUARD SMALL-CAP GROWTH INDEX FUND0.72%
Fidelity Small Cap Index Fund0.59%
Fidelity Advisor Health Care Fund0.59%

OakChart. KNSA. Cached 15 minutes.